Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · Real-Time Price · USD

6.12

+0.96 (18.72%)

At close: Aug 28, 2026, 4:00 PM EDT

5.70

-0.42 (-6.86%)

After-hours: Aug 28, 2026, 7:59 PM EDT

Quoin Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.85	3.82	3.62	2.4	2.86	7.48
Short-Term Investments	6.95	14.93	10.43	8.29	9.99	-
Cash & Short-Term Investments	10.8	18.75	14.06	10.69	12.85	7.48
Cash Growth	38.64%	33.35%	31.44%	-16.79%	71.78%	2210.70%
Prepaid Expenses	0.16	1.26	0.87	0.59	0.52	0.72
Other Current Assets	0.68	-	-	-	-	-
Total Current Assets	11.64	20.01	14.93	11.29	13.37	8.2
Other Intangible Assets	0.33	0.38	0.48	0.58	0.7	0.81
Other Long-Term Assets	-	-	0.3	0.3	0.38	0.35
Total Assets	11.97	20.39	15.71	12.17	14.46	9.36

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.11	1.26	0.91	0.53	0.61	0.92
Accrued Expenses	2.9	3.68	2.68	2.45	2.32	2.43
Current Portion of Long-Term Debt	0.6	0.6	0.6	0.6	0.6	0.6
Other Current Liabilities	-	-	-	-	-	0.62
Total Current Liabilities	6.61	5.55	4.18	3.58	3.53	4.58
Long-Term Debt	1.42	1.72	2.32	2.92	3.52	4.12
Total Liabilities	8.04	7.27	6.5	6.51	7.05	8.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	85.27	84.09	64.37	51.87	47.86	31.66
Retained Earnings	-81.34	-70.97	-55.17	-46.2	-37.52	-28.07
Treasury Stock	-	-	-	-	-2.93	-2.93
Comprehensive Income & Other	-0	-0	-	-	-	-
Shareholders' Equity	3.93	13.12	9.2	5.66	7.41	0.66
Total Liabilities & Equity	11.97	20.39	15.71	12.17	14.46	9.36

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.02	2.32	2.92	3.52	4.12	4.72
Net Cash (Debt)	8.78	16.42	11.13	7.17	8.73	2.76
Net Cash Growth	69.87%	47.50%	55.25%	-17.85%	216.41%	-
Net Cash Per Share	4.01	15.37	84.50	278.59	-	-
Filing Date Shares Outstanding	2.01	1.8	0.59	0.11	0.03	-
Total Common Shares Outstanding	2.01	1.5	0.26	0.03	0.01	-
Working Capital	5.02	14.46	10.75	7.7	9.84	3.62
Book Value Per Share	1.96	8.76	36.00	200.81	641.72	-
Tangible Book Value	3.6	12.74	8.72	5.08	6.7	-0.15
Tangible Book Value Per Share	1.79	8.50	34.11	180.13	580.68	-

SEC Filings: 10-K · 10-Q